Buy EXONDYS 51 -500mg Eteplirsen

EXONDYS 51 -500mg (Eteplirsen) is an injectable medication used for certain types of muscular dystrophy. Store between 2-8°C and protect from light. Consult healthcare provider for suitability.

Strength

500mg/10ml

Storage

2-8°

Manufacturer / TM Owner

Sarepta Therapeutics, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

EXONDYS 51 -500mg is prescribed for patients with confirmed mutations amenable to exon 51 skipping in the DMD gene. It is used to treat Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 51 skipping. This medication helps slow disease progression by targeting the underlying genetic cause.

Side Effects

After administration, EXONDYS 51 -500mg works at the cellular level to promote production of a functional dystrophin protein. Patients may experience improved muscle function over time with consistent use. Individual responses vary based on disease stage and treatment duration.

Precautions & Warnings

EXONDYS 51 -500mg must be handled and administered by a healthcare professional. Keep vials refrigerated between 2-8°C and protect from light. Do not freeze or shake vigorously. Inform your doctor about all medications and conditions before starting treatment.

Avoid Interactions

Limited data exists on drug interactions with EXONDYS 51 -500mg. No specific interactions have been identified, but caution is advised when combining with other medications. Always disclose all current medications to your healthcare provider before treatment begins.

References

Frequently Asked Questions

EXONDYS 51 is used to treat Duchenne muscular dystrophy in patients with a specific genetic mutation.

It is given as an intravenous infusion by a healthcare professional in a clinical setting.

No, it must be kept refrigerated between 2-8°C and protected from light.

Common effects may include headache, vomiting, and infusion-related reactions.

EXONDYS 51 is not a cure but may help slow disease progression in eligible patients.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.